Idera Pharmaceuticals Inc (NASDAQ:IDRA)

4.87
Delayed Data
As of Feb 27
 -0.27 / -5.25%
Today’s Change
1.94
Today|||52-Week Range
6.87
+10.43%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues16.1M53.0K51.0K47.0K
 
 
 
 
 
Depreciation And Amortization799.0K494.0K251.0K137.0K
 
 
 
 
 
 
Operating ExpensesGross Income15.3M------
 
 
General Expenses33.3M25.4M19.7M18.1M
 
 
 
 
 
Research And Development24.2M18.0M13.7M10.5M
 
 
 
 
 
Total Operating Expenses34.1M25.9M20.0M18.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-18.0M-25.9M-19.9M-18.2M
 
 
 
 
 
Extraordinary Credit0.002.0M675.0K0.00
 
 
 
Interest Expense On Debt2.0K0.000.000.00
 
 
Other Expenses-94.0K75.0K-23.0K-68.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.0M-23.8M-19.2M-18.2M
 
 
 
 
 
Preferred Dividend0.00-4.5M-3.2M-2.9M
 
 
 
 
Net Income-18.0M-23.8M-19.2M-18.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.1M27.6M27.6M43.9M
 
 
 
 
 
Shares To Calculate EPS Diluted25.1M27.6M27.6M43.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.71-$1.03-$0.81-$0.48
 
 
 
 
 
EPS Diluted-$0.71-$1.03-$0.81-$0.48
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account